Key facts
- PREVE’s last known valuation is $4.2M (Apr 2025).
- It has raised $2.1M; the latest was Seed Round ($2.1M) in Apr 2025.
- Notable investors include Startmate, Archangel Ventures, Carthona Capital, Black Sheep Capital, Alexey Mitko — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for PREVE
- ·The full record, as it builds
Funding rounds
No funding rounds for PREVE are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About PREVE
Operator of a clinic management system intended to help physio clinics. The company's system is used for engaging patients and treatment, enabling physiotherapists to focus on their care rather than the management of their clinics.
- Sector
- Healthcare
- HQ
- Australia
- Founded
- 2023
- Employees
- 5
- Website
- preve.co/
- Ownership
- Privately Held (backing)
PREVE doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in PREVE shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on PREVE in its N-PORT filings yet. We sweep new filings monthly.